Among the prognosis-related lncRNAs in HCC, SNHG3, SNHG4, and NRAV have been reported to function in bladder cancer (46), non-small cell lung cancer (47), osteosarcoma (48), colorectal cancer (49), breast cancer (50), gastric cancer (51), and glioma (52) through interactive molecular pathway studies. Here, NRAV is linked to hepatocellular carcinoma.